This article helps you evaluate both options against clinical evidence and your own health context, including how genetic factors may inform your medication selection process
Once melanoma has metastasized, it is more challenging to treat
For combined pathway studies, a BPC 157 and TB 500 blend may be useful
Understand immediate performance and recovery benefits (right after treatment) and benefits 2472 hours after exercise
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Worried about out-of-pocket costs